AI-Designed Vaccine Targets Coronavirus Family, Early Trial Shows Promise
TL;DR
Researchers at the University of Cambridge used AI to design a DNA-based vaccine targeting immutable components of the sarbecovirus family (which includes SARS and SARS-CoV-2). In a small first-in-human trial with 39 participants, the AI-designed vaccine activated antibodies and was well tolerated across doses, suggesting potential for a universal coronavirus vaccine, though the durability and magnitude of protection require further study.
Topics:healthscience#ai-designed-vaccine#cambridge#coronaviruses#dna-vaccine#science#universal-vaccine
- Doctors Inject Human Subjects With First Vaccine Designed by AI Yahoo
- New ‘universal vaccine’ technology could protect us from future virus outbreaks University of Cambridge
- AI-designed 'universal vaccine' passes first human clinical trial, could prevent future pandemics Fox News
- 'World-first' vaccine designed by artificial intelligence BBC
- Editorial: Skepticism—and success—matters on AI and vaccines C&EN
Want the full story? Read the original reporting
Read on Yahoo